Implanet S.A. (EPA: ALIMP)
France
· Delayed Price · Currency is EUR
0.110
+0.001 (0.46%)
Dec 27, 2024, 5:29 PM CET
Implanet Revenue
Implanet had revenue of 4.12M EUR in the half year ending June 30, 2024, with 0.12% growth. This brings the company's revenue in the last twelve months to 7.30M, down -10.85% year-over-year. In the year 2023, Implanet had annual revenue of 7.45M, down -7.24%.
Revenue (ttm)
7.30M
Revenue Growth
-10.85%
P/S Ratio
1.12
Revenue / Employee
169.67K
Employees
41
Market Cap
13.75M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.45M | -581.00K | -7.24% |
Dec 31, 2022 | 8.03M | 1.89M | 30.75% |
Dec 31, 2021 | 6.14M | 2.25M | 57.76% |
Dec 31, 2020 | 3.89M | -3.52M | -47.46% |
Dec 31, 2019 | 7.41M | 687.00K | 10.22% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Eurofins Scientific SE | 6.72B |
Ipsen S.A. | 3.44B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |